ADXN
Price
$7.45
Change
+$0.35 (+4.93%)
Updated
Apr 2 closing price
Capitalization
7.4M
KALV
Price
$11.09
Change
-$0.06 (-0.54%)
Updated
Apr 2 closing price
Capitalization
551.35M
91 days until earnings call
Ad is loading...

ADXN vs KALV

Header iconADXN vs KALV Comparison
Open Charts ADXN vs KALVBanner chart's image
Addex Therapeutics
Price$7.45
Change+$0.35 (+4.93%)
Volume$7.49K
Capitalization7.4M
KalVista Pharmaceuticals
Price$11.09
Change-$0.06 (-0.54%)
Volume$918.57K
Capitalization551.35M
ADXN vs KALV Comparison Chart
Loading...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADXN vs. KALV commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a StrongBuy and KALV is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ADXN: $7.45 vs. KALV: $11.09)
Brand notoriety: ADXN and KALV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 78% vs. KALV: 173%
Market capitalization -- ADXN: $7.4M vs. KALV: $551.35M
ADXN [@Biotechnology] is valued at $7.4M. KALV’s [@Biotechnology] market capitalization is $551.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 2 FA rating(s) are green whileKALV’s FA Score has 0 green FA rating(s).

  • ADXN’s FA Score: 2 green, 3 red.
  • KALV’s FA Score: 0 green, 5 red.
According to our system of comparison, ADXN is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALV’s TA Score shows that 4 TA indicator(s) are bullish.

  • KALV’s TA Score: 4 bullish, 4 bearish.

Price Growth

ADXN (@Biotechnology) experienced а -3.62% price change this week, while KALV (@Biotechnology) price change was -8.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

ADXN is expected to report earnings on Apr 30, 2024.

KALV is expected to report earnings on Jul 03, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KALV($551M) has a higher market cap than ADXN($7.4M). KALV YTD gains are higher at: 30.933 vs. ADXN (6.429). ADXN has higher annual earnings (EBITDA): -12.19M vs. KALV (-173.23M). KALV has more cash in the bank: 253M vs. ADXN (3.35M). ADXN has less debt than KALV: ADXN (43.8K) vs KALV (5.78M). ADXN has higher revenues than KALV: ADXN (556K) vs KALV (0).
ADXNKALVADXN / KALV
Capitalization7.4M551M1%
EBITDA-12.19M-173.23M7%
Gain YTD6.42930.93321%
P/E RatioN/AN/A-
Revenue556K0-
Total Cash3.35M253M1%
Total Debt43.8K5.78M1%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KALV
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRG102.884.35
+4.41%
NRG Energy
BOXL1.500.06
+4.17%
Boxlight Corporation
BRC72.511.25
+1.75%
Brady Corp
XNCR9.820.13
+1.34%
Xencor
HWBK27.980.20
+0.72%
Hawthorn Bancshares

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
+4.93%
ANVS - ADXN
40%
Loosely correlated
+6.71%
CVM - ADXN
39%
Loosely correlated
-4.15%
AGEN - ADXN
24%
Poorly correlated
+1.87%
KALV - ADXN
24%
Poorly correlated
-0.58%
SLS - ADXN
23%
Poorly correlated
N/A
More

KALV and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with ATXS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
-0.58%
ATXS - KALV
45%
Loosely correlated
+2.22%
FATE - KALV
43%
Loosely correlated
+1.70%
AVIR - KALV
43%
Loosely correlated
+1.05%
IDYA - KALV
42%
Loosely correlated
+10.70%
AURA - KALV
40%
Loosely correlated
+4.76%
More